Nachrichten

AI in Clinical Trials - Global Strategic Business Report 2026: Secure Share of a US$4.1 Billion Market by 2032 with IQVIA, Microsoft, Tempus AI, and Saama

Yahoo

Company Logo Dublin, Nov. 18, 2026 (GLOBE NEWSWIRE) -- "AI in Clinical Trials - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global artificial intelligence (AI) in clinical trials market was valued at US$1.6 billion in 2025 and is projected to reach US$4.1 billion by 2032, expanding at a compound annual growth rate (CAGR) of 14% during the forecast period. Market growth is being supported by rising drug development costs, increasingly complex clinical protocols, demand for personalized therapies, and the pharmaceutical industry's focus on accelerating time to market.

Vollstaendiges Veytics-Briefing lesen

Wir zeigen den wichtigsten Punkt oeffentlich. Erstellen Sie ein kostenloses Konto, um den vollstaendigen Artikel zu lesen, ihn zu speichern, zu diskutieren und mit Markt- und OSINT-Kontext zu verbinden.